Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially...

Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, dem...

Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...

Following trade suspension with India, Pakistani health authorities are taking "emergency preparedness" steps to secure pharmaceutical supp...

India's Thiruvananthapuram has become a vaccine superpower, producing 60 per cent of the world's vaccines, with significant contributions f...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inh...

Iran is mourning the tragic loss of President Ebrahim Raisi, Foreign Minister Hossein Amir-Abdollahian, and other officials in a helicopter...

In 2024, several of Baba Vanga's predictions appear to be coming true, including the development of a cancer vaccine by Russia and the onse...

Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing can...

A study published in The Lancet's eClinicalMedicine journal reveals that over 1.3 million lives are lost annually due to tobacco-related ca...

The Lancet revealed that Africa followed Asia (20%), Europe (10%) and Latin America (10%) and more than half of deaths were estimated in As...

The BJP leader said the country gave 18.50 crore doses of the vaccine to 100 countries. Out of them, 1.43 crore were given free of cost to ...

In a statement, Assad's office said the first couple did PCR tests after they experienced minor symptoms consistent with the COVID-19 illne...

Some researchers believe the strong immune response that caused problems with gene therapy makes these vectors well suited to vaccines, whe...

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...

The Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.

There will be 323 million in India by 2050 in the 65-plus age group as per a report by The Economist Intelligence Unit.